Chemours (CC) 2025 Earnings Outlook for Investors
Chemours faces a year of nuanced cycles in pigments and fluorochemicals. This guide breaks down what to watch in chem...
Compare rebalancing frequency between index funds and target-date funds and what that means for risk, fees, and long-term performance. A quick look at when to expect adjustments.
28,361 articlesChemours faces a year of nuanced cycles in pigments and fluorochemicals. This guide breaks down what to watch in chem...
Six non-AI chip makers could be poised to benefit from the AI boom, as demand broadens beyond headline AI chips. Here...
A sharp month-long sell-off pushed AeroVironment shares down by more than 20%. This article breaks down the catalysts...
Tesla is steering its $25 billion capex plan beyond cars and into AI and robotics. This shift could transform margins...
Teva has climbed more than 100% in the last year, and analysts remain cautiously optimistic. Here’s why wall street t...
IonQ just posted revenue that more than tripled for the third straight quarter, but the stock sold off despite the ga...
Investors are seeing renewed momentum in xanadu quantum technologies stock as talk of government support and industry...
Celsius shares have fallen more than 50% from their intraday peaks as growth from newly acquired brands accelerates. ...
Investors are weighing growth, profitability, and risk after the newest earnings release. Here’s a practical, plain-l...
Bumble stock surged after the dating app maker teased new AI-powered features and provided market context on growth. ...
Qualcomm is pivoting from phones to AI chips and software, aiming to blend edge intelligence with data-center power. ...
Chevron’s move to explore pipeline routes that bypass the Strait of Hormuz could change oil flows and stock risk prof...